Glixis Therapeutics Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $300K
Latest Deal Amount
  • Investors
  • 2

Glixis Therapeutics General Information


Developer of novel therapies for autoimmune diseases. The company focuses on glyco-engineering novel therapies for autoimmune disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 122 Calistoga Road 346
  • Santa Rosa, CA 95409
  • United States
+1 (818) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Glixis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 12-Jun-2014 $300K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Glixis Therapeutics’s complete valuation and funding history, request access »

Glixis Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Ani Oganesyan Ph.D Chief Executive Officer
To view Glixis Therapeutics’s complete executive team members history, request access »

Glixis Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
To view Glixis Therapeutics’s complete investors history, request access »